Dr. Reddy’s推迟仿制Ozempic供应
2026-07-09 05:11:27
据彭博社报道，Dr. Reddy’s Laboratories Ltd.称，因在部分司美格鲁肽批次中发现活性药物成分存在未披露问题，将推迟其仿制Ozempic药物的商业化生产。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
股票市场 | 高盛：日本并购活动仍处初期Next article：
地缘政治 | 泰国宪法法院放行120亿美元危机贷款
